New digital and blood tests could spot Alzheimer's years earlier.

NCT ID NCT07284264

First seen Jan 04, 2026 · Last updated Jun 12, 2026 · Updated 23 times

Summary

This study aims to improve early detection of Alzheimer's disease in adults aged 50 and older who have no memory complaints. Participants will first complete a quick digital screening (questionnaire and cognitive test), and those at risk will have blood tests to confirm Alzheimer's-related changes. The goal is to create a simple, stepwise approach that can be used widely in communities.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEMENTIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • General Hospital of Ningxia Medical University

    RECRUITING

    Ningxiang, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hainan Medical University

    RECRUITING

    Hainan, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shenzhen Center For Chronic Disease Control

    RECRUITING

    Shenzhen, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Hospital of China Medical Unversity

    RECRUITING

    Shenyang, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Xuanwu Hospital, Capital Medical University

    RECRUITING

    Beijing, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Yichun People'S Hospital

    RECRUITING

    Yichun, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.